Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it "taxol".
Scope of the Report:
This report focuses on the Paclitaxel in North America and Europe market, especially in United States, United Kingdom, Canada, Germany, France, Italy and Spain. This report categorizes the market based on manufacturers, countries/Regions, type and application.
Market Segment by Manufacturers, this report covers
Phyton
ScinoPharm
Novasep
Samyang
Polymed
TAPI (Teva)
Fresenius-kabi
Huiang biopharma
Southpharma
Yunnan Hande
Hainan Yew Pharm
Jiangsu Yew Biotechnology
Market Segment by Countries, covering
United States
United Kingdom
Canada
Germany
France
Italy
Spain
Market Segment by Type, covers
Natural Paclitaxel API
Semi-synthetic Paclitaxel API
Market Segment by Applications, can be divided into
Ovarian Cancer
Cervical Cancer
Breast Cancer
Other
There are 19 Chapters to deeply display the North America and Europe Paclitaxel market.
Chapter 1, to describe Paclitaxel Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;
Chapter 2, to analyze the manufacturers of Paclitaxel, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the North America and Europe market by countries, covering United States, United Kingdom, Canada, France, Germany, Italy and Spain, with sales, price, revenue and market share of Paclitaxel, for each country, from 2013 to 2018;
Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2013 to 2018;
Chapter 7, 8, 9, 10, 11, 12 and 13 to analyze the key countries by manufacturers, Type and Application, covering 7 countries, with sales, revenue and market share by manufacturers, types and applications;
Chapter 14, Paclitaxel market forecast, by countries, type and application, with sales, price, revenue and growth rate forecast, from 2018 to 2023;
Chapter 15, to analyze the manufacturing cost, key raw materials and manufacturing process, etc.
Chapter 16, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);
Chapter 17, to describe sales channel, distributors, traders, dealers, etc.
Chapter 18 and 19, to describe the research findings and conclusion, appendix, methodology and data source.
Frequently Asked Questions
These dominant industry players use well planned strategies to occupied highest market share in this market. Some of the top players in [Keyword] business includes.
[Company list]
As per [Keyword] market analysis, North America is forecasted to occupied major share in the [Keyword] market.
The statistical data of the dominant industry player of [Keyword] market can be acquired from the company profile segment described in the report. This segment come up with analysis of major player’s in the [Keyword] market, also their last five-year revenue, segmental, product offerings, key strategies adopted and geographical revenue produced.
The report come up with a segment of the [Keyword] market based on Type, Region, and Application, Also offer a determined view on the [Keyword] market.
The report offers a nitty-gritty estimation of the market by providing data on various viewpoints that incorporate, restraints, drivers, and opportunities threats. This data can help in making suitable decisions for stakeholders before investing.
The sample report for [Keyword] market can be received after the apply from the website.
Table Of Content
Table of Contents
1 Market Overview
1.1 Paclitaxel Introduction
1.2 Market Analysis by Type
1.2.1 Natural Paclitaxel API
1.2.2 Semi-synthetic Paclitaxel API
1.3 Market Analysis by Applications
1.3.1 Ovarian Cancer
1.3.2 Cervical Cancer
1.3.3 Breast Cancer
1.3.4 Other
1.4 Market Analysis by Countries
1.4.1 United States Status and Prospect (2013-2023)
1.4.2 Canada Status and Prospect (2013-2023)
1.4.3 United Kingdom Status and Prospect (2013-2023)
1.4.4 Germany Status and Prospect (2013-2023)
1.4.5 France Status and Prospect (2013-2023)
1.4.6 Italy Status and Prospect (2013-2023)
1.4.7 Spain Status and Prospect (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Phyton
2.1.1 Business Overview
2.1.2 Paclitaxel Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Phyton Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 ScinoPharm
2.2.1 Business Overview
2.2.2 Paclitaxel Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 ScinoPharm Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Novasep
2.3.1 Business Overview
2.3.2 Paclitaxel Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Novasep Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Samyang
2.4.1 Business Overview
2.4.2 Paclitaxel Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Samyang Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Polymed
2.5.1 Business Overview
2.5.2 Paclitaxel Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Polymed Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 TAPI (Teva)
2.6.1 Business Overview
2.6.2 Paclitaxel Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 TAPI (Teva) Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Fresenius-kabi
2.7.1 Business Overview
2.7.2 Paclitaxel Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Fresenius-kabi Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Huiang biopharma
2.8.1 Business Overview
2.8.2 Paclitaxel Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 Huiang biopharma Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Southpharma
2.9.1 Business Overview
2.9.2 Paclitaxel Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 Southpharma Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Yunnan Hande
2.10.1 Business Overview
2.10.2 Paclitaxel Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 Yunnan Hande Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Hainan Yew Pharm
2.11.1 Business Overview
2.11.2 Paclitaxel Type and Applications
2.11.2.1 Type 1
2.11.2.2 Type 2
2.11.3 Hainan Yew Pharm Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Jiangsu Yew Biotechnology
2.12.1 Business Overview
2.12.2 Paclitaxel Type and Applications
2.12.2.1 Type 1
2.12.2.2 Type 2
2.12.3 Jiangsu Yew Biotechnology Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 North America and Europe Paclitaxel Market Competition, by Manufacturer
3.1 North America and Europe Paclitaxel Sales and Market Share by Manufacturer (2016-2017)
3.2 North America and Europe Paclitaxel Revenue and Market Share by Manufacturer (2016-2017)
3.2.1 North America and Europe Paclitaxel Revenue by Manufacturer (2016-2017)
3.2.2 North America and Europe Paclitaxel Revenue Market Share by Manufacturer (2016-2017)
3.3 North America and Europe Paclitaxel Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Paclitaxel Manufacturer Market Share (2016-2017)
3.4.2 Top 5 Paclitaxel Manufacturer Market Share (2016-2017)
3.5 Market Competition Trend
4 North America and Europe Paclitaxel Market Analysis by Countries/Regions
4.1 North America and Europe Paclitaxel Sales Market Share by Countries/Regions
4.2 North America and Europe Paclitaxel Sales by Countries/Regions (2013-2018)
4.2.1 North America and Europe Paclitaxel Sales by Countries/Regions (2013-2018)
4.2.2 North America and Europe Paclitaxel Sales Market Share by Countries (2013-2018)
4.3 North America and Europe Paclitaxel Revenue (Value) by Countries (2013-2018)
4.3.1 North America and Europe Paclitaxel Revenue and Growth Rate (2013-2018)
4.3.2 North America and Europe Paclitaxel Revenue Market Share by Countries (2013-2018)
5 North America and Europe Market Segmentation Paclitaxel by Type
5.1 North America and Europe Paclitaxel Sales, Revenue and Market Share by Type (2013-2018)
5.1.1 North America and Europe Paclitaxel Sales and Market Share by Type (2013-2018)
5.1.2 North America and Europe Paclitaxel Revenue and Market Share by Type (2013-2018)
5.2 Natural Paclitaxel API Sales Growth and Price
5.2.1 North America and Europe Natural Paclitaxel API Sales Growth (2013-2018)
5.2.2 North America and Europe Natural Paclitaxel API Price (2013-2018)
5.3 Semi-synthetic Paclitaxel API Sales Growth and Price
5.3.1 North America and Europe Semi-synthetic Paclitaxel API Sales Growth (2013-2018)
5.3.2 North America and Europe Semi-synthetic Paclitaxel API Price (2013-2018)
6 North America and Europe Market Segmentation Paclitaxel by Application
6.1 North America and Europe Paclitaxel Sales Market Share by Application (2013-2018)
6.2 Ovarian Cancer Sales Growth (2013-2018)
6.3 Cervical Cancer Sales Growth (2013-2018)
6.4 Breast Cancer Sales Growth (2013-2018)
6.5 Other Sales Growth (2013-2018)
7 United States Paclitaxel Sales, Revenue, by Type, Application and Manufacturers
7.1 United States Paclitaxel Revenue, Sales and Growth Rate (2013-2018)
7.2 United States Paclitaxel Sales and Market Share by Type (2013-2018)
7.2.1 United States Paclitaxel Sales by Type (2013-2018)
7.2.2 United States Paclitaxel Sales Market Share by Type (2013-2018)
7.3 United States Paclitaxel Sales and Market Share by Application (2013-2018)
7.3.1 United States Paclitaxel Sales by Application (2013-2018)
7.3.2 United States Paclitaxel Sales Market Share by Application (2013-2018)
7.4 United States Paclitaxel Sales, Revenue and Market Share by Manufacturer (2016-2017)
7.4.1 United States Paclitaxel Sales and Market Share by Manufacturer (2016-2017)
7.4.2 United States Paclitaxel Revenue and Market Share by Manufacturer (2016-2017)
7.5 United States Paclitaxel Export and Import (2013-2018)
8 United Kingdom Paclitaxel Sales, Revenue, by Type, Application and Manufacturers
8.1 United Kingdom Paclitaxel Revenue, Sales and Growth Rate (2013-2018)
8.2 United Kingdom Paclitaxel Sales and Market Share by Type (2016-2017)
8.2.1 United Kingdom Paclitaxel Sales by Type (2013-2018)
8.2.2 United Kingdom Paclitaxel Sales Market Share by Type (2013-2018)
8.3 United Kingdom Paclitaxel Sales and Market Share by Application (2013-2018)
8.3.1 United Kingdom Paclitaxel Sales by Application (2013-2018)
8.3.2 United Kingdom Paclitaxel Sales Market Share by Application (2013-2018)
8.4 United Kingdom Paclitaxel Sales, Revenue and Market Share by Manufacturer (2016-2017)
8.4.1 United Kingdom Paclitaxel Sales and Market Share by Manufacturer (2016-2017)
8.4.2 United Kingdom Paclitaxel Revenue and Market Share by Manufacturer (2016-2017)
8.5 United Kingdom Paclitaxel Export and Import (2013-2018)
9 Canada Paclitaxel Sales, Revenue, by Type, Application and Manufacturers
9.1 Canada Paclitaxel Revenue, Sales and Growth Rate (2013-2018)
9.2 Canada Paclitaxel Sales and Market Share by Type (2013-2018)
9.2.1 Canada Paclitaxel Sales by Type (2013-2018)
9.2.2 Canada Paclitaxel Sales Market Share by Type (2013-2018)
9.3 Canada "&Sheet1!$B$1&" Sales and Market Share by Application (2013-2018)"
9.3.1 Canada Paclitaxel Sales by Application (2013-2018)
9.3.2 Canada Paclitaxel Sales Market Share by Application (2013-2018)
9.4 Canada Paclitaxel Sales, Revenue and Market Share by Manufacturer (2016-2017)
9.4.1 Canada Paclitaxel Sales and Market Share by Manufacturer (2016-2017)
9.4.2 Canada Paclitaxel Revenue and Market Share by Manufacturer (2016-2017)
9.5 Canada Paclitaxel Export and Import (2013-2018)
10 Germany Paclitaxel Sales, Revenue, by Type, Application and Manufacturers
10.1 Germany Paclitaxel Revenue, Sales and Growth Rate (2013-2018)
10.2 Germany Paclitaxel Sales and Market Share by Type (2013-2018)
10.2.1 Germany Paclitaxel Sales by Type (2013-2018)
10.2.2 Germany Paclitaxel Sales Market Share by Type (2013-2018)
10.3 Germany Paclitaxel Sales and Market Share by Application (2013-2018)
10.3.1 Germany Paclitaxel Sales by Application (2013-2018)
10.3.2 Germany Paclitaxel Sales Market Share by Application (2013-2018)
10.4 Germany Paclitaxel Sales, Revenue and Market Share by Manufacturer (2016-2017)
10.4.1 Germany Paclitaxel Sales and Market Share by Manufacturer (2016-2017)
10.4.2 Germany Paclitaxel Revenue and Market Share by Manufacturer (2016-2017)
10.5 Germany Paclitaxel Export and Import (2013-2018)
11 France Paclitaxel Sales, Revenue, by Type, Application and Manufacturers
11.1 France Paclitaxel Revenue, Sales and Growth Rate (2013-2018)
11.2 France Paclitaxel Sales and Market Share by Type (2013-2018)
11.2.1 France Paclitaxel Sales by Type (2013-2018)
11.2.2 France Paclitaxel Sales Market Share by Type (2013-2018)
11.3 France "&Sheet1!$B$1&" Sales by Application (2013-2018)"
11.3.1 France Paclitaxel Sales by Application (2013-2018)
11.3.2 France Paclitaxel Sales Market Share by Application (2013-2018)
11.4 France Paclitaxel Sales, Revenue and Market Share by Manufacturer (2016-2017)
11.4.1 France Paclitaxel Sales and Market Share by Manufacturer (2016-2017)
11.4.2 France Paclitaxel Revenue and Market Share by Manufacturer
11.5 France Paclitaxel Export and Import (2013-2018)
12 Italy Paclitaxel Sales, Revenue, by Type, Application and Manufacturers
12.1 Italy Paclitaxel Revenue, Sales and Growth Rate (2013-2018)
12.2 Italy Paclitaxel Sales and Market Share by Type (2013-2018)
12.2.1 Italy Paclitaxel Sales by Type (2013-2018)
12.2.2 Italy Paclitaxel Sales Market Share by Type (2013-2018)
12.3 Italy Paclitaxel Sales and Market Share by Application (2013-2018)
12.3.1 Italy Paclitaxel Sales by Application (2013-2018)
12.3.2 Italy Paclitaxel Sales Market Share by Application (2013-2018)
12.4 Italy Paclitaxel Sales, Revenue and Market Share by Manufacturer (2016-2017)
12.4.1 Italy Paclitaxel Sales and Market Share by Manufacturer (2016-2017)
12.4.2 Italy Paclitaxel Revenue and Market Share by Manufacturer (2016-2017)
12.5 Italy Paclitaxel Export and Import (2013-2018)
13 Spain Paclitaxel Sales, Revenue, by Type, Application and Manufacturers
13.1 Spain Paclitaxel Revenue, Sales and Growth Rate (2013-2018)
13.2 Spain Paclitaxel Sales and Market Share by Type (2013-2018)
13.2.1 Spain Paclitaxel Sales by Type (2013-2018)
13.2.2 Spain Paclitaxel Sales Market Share by Type (2013-2018)
13.3 Spain Paclitaxel Sales by Application (2013-2018)
13.3.1 Spain Paclitaxel Sales by Application (2013-2018)
13.3.2 Spain Paclitaxel Sales Market Share by Application (2013-2018)
13.4 Spain Paclitaxel Sales, Revenue and Market Share by Manufacturer (2016-2017)
13.4.1 Spain Paclitaxel Sales and Market Share by Manufacturer (2016-2017)
13.4.2 Spain Paclitaxel Revenue and Market Share by Manufacturer (2016-2017)
13.5 Spain Paclitaxel Export and Import (2013-2018)
14 Paclitaxel Market Forecast (2018-2023)
14.1 North America and Europe Paclitaxel Sales, Revenue and Growth Rate (2018-2023)
14.2 Paclitaxel Market Forecast by Countries/Regions (2018-2023)
14.2.1 United States Paclitaxel Sales and Growth Rate Forecast (2018-2023)
14.2.2 United Kingdom Paclitaxel Sales and Growth Rate Forecast (2018-2023)
14.2.3 Canada Paclitaxel Sales and Growth Rate Forecast (2018-2023)
14.2.4 Germany Paclitaxel Sales and Growth Rate Forecast (2018-2023)
14.2.5 France Paclitaxel Sales and Growth Rate Forecast (2018-2023)
14.2.6 Italy Paclitaxel Sales and Growth Rate Forecast (2018-2023)
14.2.7 Spain Paclitaxel Sales and Growth Rate Forecast (2018-2023)
14.3 Paclitaxel Market Forecast by Type (2018-2023)
14.3.1 North America and Europe Paclitaxel Sales Forecast by Type (2018-2023)
14.3.2 North America and Europe Paclitaxel Market Share Forecast by Type (2018-2023)
14.4 Paclitaxel Market Forecast by Application (2018-2023)
14.4.1 North America and Europe Paclitaxel Sales Forecast by Application (2018-2023)
14.4.2 North America and Europe Paclitaxel Market Share Forecast by Application (2018-2023)
15 Paclitaxel Manufacturing Cost Analysis
15.1 Paclitaxel Key Raw Materials Analysis
15.1.1 Key Raw Materials
15.1.2 Price Trend of Key Raw Materials
15.1.3 Key Suppliers of Raw Materials
15.1.4 Market Concentration Rate of Raw Materials
15.2 Proportion of Manufacturing Cost Structure
15.2.1 Raw Materials
15.2.2 Labor Cost
15.2.3 Manufacturing Expenses
15.3 Manufacturing Process Analysis of Paclitaxel
16 Industrial Chain, Sourcing Strategy and Downstream Buyers
16.1 Paclitaxel Industrial Chain Analysis
16.2 Upstream Raw Materials Sourcing
16.3 Raw Materials Sources of Paclitaxel Major Manufacturers in 2017
16.4 Downstream Buyers
17 Sales Channel, Distributors, Traders and Dealers
17.1 Sales Channel
17.1.1 Direct Marketing
17.1.2 Indirect Marketing
17.1.3 Marketing Channel Future Trend
17.2 Distributors, Traders and Dealers
18 Research Findings and Conclusion
19 Appendix
19.1 Methodology
19.2 Data Source
Inquiry For Buying
North America and Europe Paclitaxel
Please fill out the form. We will contact you within 24 hours:
All fields required...
Request Sample
North America and Europe Paclitaxel
Please fill out the form. We will contact you within 24 hours:
All fields required...
